title: Biological terrorism and the allergist's office practice.
abstract: During the anthrax outbreak and threat in Trenton (2001), our allergy practice experienced increased visits from approximately 50 of our regular patients with symptoms they believed resulted from anthrax exposure. In all cases, their symptoms were caused by a combination of an exacerbation of their underlying allergic disease and anxiety because of possible exposure to anthrax. Our objective is to present an orderly approach to the allergist's outpatients presenting with possible exposure to a bioterrorist's agent. The 10 precepts of approach to the management of a biological casualty (index of suspicion, protect yourself, patient assessment, decontaminate, diagnose, treat, infection control, alert authorities, assist in investigation, and maintain proficiency) and the epidemiological characteristics of a biological attack are discussed. In table form, we compared the signs and symptoms of the most common outpatient consultations to an allergist's office practice (chronic rhinitis, asthma, food allergy, venom allergy, atopic dermatitis, drug allergy, chronic urticaria, acute urticaria, immunodeficiency, and anaphylaxis) with those of likely bioterrorism threats. Descriptions of smallpox, plague, tularemia, anthrax, viral hemorrhagic fevers, Q fever, brucellosis, Venezuelan equine encephalitis, glanders, and melioidosis are presented. Patients may readily mistake their allergic symptoms with those of infection with a bioterrorist's agent. At the same time, the allergist may be faced with one of his own chronic patients presenting with symptoms resembling their allergic disease but actually caused by one of the aforementioned pathogens.
authors.affiliation: Department of Medicine, St. Francis Medical Center, Trenton, New Jersey, USA.
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Ricketti
authors.forename: Burke A
authors.initials: BA
authors.lastname: Cunha
authors.forename: Dennis J
authors.initials: DJ
authors.lastname: Cleri
authors.forename: Suzanne H
authors.initials: SH
authors.lastname: Shenk
authors.forename: John R
authors.initials: JR
authors.lastname: Vernaleo
authors.forename: David W
authors.initials: DW
authors.lastname: Unkle
mesh_terms: D000486:Allergy and Immunology; D000881:Anthrax / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D001424:Bacterial Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D023482:Bioterrorism / Q000517:prevention & control*; D003937:Diagnosis, Differential; D004196:Disease Outbreaks / Q000517:prevention & control*; D005512:Food Hypersensitivity / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D006967:Hypersensitivity / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D010818:Practice Patterns, Physicians'; D012221:Rhinitis, Allergic, Perennial / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D014777:Virus Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology